×

Mylan shares down on 500% price hike

1:02 PM ET Fri, 19 Aug 2016

Shares of Mylan are under pressure as word spreads about the increased price of its EpiPen drug by 500 percent. David Maris, Wells Fargo managing director, shares his take.